As Omicron infections zoom, so does Dolo's market share

Even as the country faces an alarming increase in Covid-19 infections primarily due to the Omicron variant, Dolo 650 has seen high demand as those with fever and body ache scramble to keep the pain away.

Social media platforms like Twitter and Instagram have seen a swarm of memes related to the increased demand for Dolo 650, which is sold by Bengaluru-based Micro Labs as a result of which, the company’s market share boomed in December, a trend also seen in January so far. Dolo 650 has 650mg of paracetamol, which is an antipyretic (for fever) and analgesic (for pain relief).

Concerns have now emerged about the indirect promotion of prescription medicines, their irrational use and inappropriate self-medication. Experts say that the promotion and advertisement of medicines is in violation of the Drugs and Magic Remedies Act, and should not be allowed to go unchecked. Since paracetamol is a scheduled drug, it cannot be promoted under the Act for fever.

“Many patients are self-medicating without even a proper diagnosis — this may even lead to serious side-effects,” Indian Medical Association’s general secretary Dr Jayesh Lele told TOI.

“Dolo has become a four-letter word brand of great utility and ubiquity for many. This, in turn, has led to a Dolo 650-in-every-house kind of movement. For an OTC (over-the-counter), this is a super-brand status,” brand strategy expert Harish Bijoor said. Micro Labs was taken by surprise. Executive VP (marketing) Jayaraj Govindaraju said, “We have been promoting it as per law, and there are statutory warnings on the pack.” While paracetamol is known to be a well-tolerated drug when taken within prescribed dose range, overdosage may be associated with severe liver and pancreatic injury, they add.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.